home *** CD-ROM | disk | FTP | other *** search
- Xref: sparky talk.politics.drugs:8212 talk.politics.medicine:654 sci.med:24303
- Path: sparky!uunet!cs.utexas.edu!qt.cs.utexas.edu!yale.edu!not-for-mail
- From: drayer-rebecca@yale.edu (Rebecca Drayer)
- Newsgroups: talk.politics.drugs,talk.politics.medicine,sci.med
- Subject: Re: From _Scientific American_
- Date: 22 Jan 1993 15:08:37 -0500
- Organization: Yale University Science & Engineering, New Haven, CT 06520-2158
- Lines: 17
- Message-ID: <1jpk85INN2a5@MINERVA.CIS.YALE.EDU>
- References: <1jc3mdINN9mh@mirror.digex.com> <1993Jan19.020022.911160@locus.com> <1993Jan22.094510.14223@genie.slhs.udel.edu>
- NNTP-Posting-Host: minerva.cis.yale.edu
-
- In article <1993Jan22.094510.14223@genie.slhs.udel.edu> starr@genie.slhs.udel.edu (Tim Starr) writes:
- >Yep. I posted an article about the Fascist Death Authority's censorship on
- >notification of results of aspirin studies on heart disease from the Orange
- >County Register. The suppliers of aspirin are banned from telling anyone
- >on their labels that their risk of death could be decrease by 40% if they took
- >some each day. This adds about 20 grand more deaths to their body count.
-
- Was there a reason for this action? I mean, it doesn't seem conceivable
- that they would have done this completely arbitrarily. I'm not defending
- the FDA, but on the other hand, I don't want to condemn it until I know
- all the facts.
-
-
- --
- Rebecca A. Drayer, EMT-A | drayer@minerva.cis.yale.edu
- Neurobiology major | Computing Assistant
- | Silliman College, Yale University
-